PatternsRadar
Sign in

SMSPHARMASMS Pharmaceuticals Limited

NSE
473.25INR-8.10 (-1.68%)Close · 20 Nov 2026
4 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹4,432 CrMarket cap
37.8P/E (TTM)
54.0%Delivery

Filings & corporate actions

79 results filed
CSV
Next results · Q3 FY27
Expected 7 Feb 2027 – 12 Feb 2027
Estimate: filed 38–43 days after quarter end, last 5 times
Dividend
₹0.40 per share · last 22 Sept 2026
2026
  • 4 NovresultsResults · Q2 FY27 · consolidated and standalone-1.7%NSE
  • 8 OctshareholdingShareholding · 30 Sept 2026-4.7%NSE
  • 22 SeptdividendDividend · ₹0.40 per share · record 22 Sept 2026+3.6%
  • 31 JulresultsResults · Q1 FY27 · consolidated and standalone-2.8%NSE
  • 10 JulshareholdingShareholding · 30 Jun 2026-1.1%NSE
  • 22 MayresultsResults · Q4 FY26 · consolidated and standalone-3.2%NSE
  • 16 AprshareholdingShareholding · 31 Mar 2026-3.2%NSE
  • 7 FebresultsResults · Q3 FY26 · consolidated and standalone+0.7%NSE
  • 9 JanshareholdingShareholding · 31 Dec 2025-1.3%NSE

Reaction to results · all yearsrose on day 0 in 33 of 79 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY274 Nov 2026-1.7%-0.3%—1.1×
Q1 FY2731 Jul 2026-2.8%-0.5%-0.5%1.4×
Q4 FY2622 May 2026-3.2%-4.6%-0.3%2.6×
Q3 FY267 Feb 2026+0.7%+7.0%+32.2%2.4×
Q2 FY268 Nov 2025+1.3%+0.3%+10.6%34.1×
Q1 FY269 Aug 2025+2.4%+6.4%+19.5%2.0×
Q4 FY2530 May 2025-1.8%-5.5%-5.3%2.2×
Q3 FY2512 Feb 2025-3.1%-3.8%-10.6%1.8×
Q2 FY258 Nov 2024-5.0%-15.3%-14.4%1.6×
Q1 FY255 Aug 2024-9.9%-9.7%+9.9%2.3×
Q4 FY2429 May 2024-6.1%-7.0%+5.5%2.7×
Q3 FY248 Feb 2024+11.9%+14.0%+36.8%44.3×
Q2 FY248 Nov 2023-2.1%-2.4%-2.8%1.4×
Q1 FY248 Aug 2023+3.1%+2.0%+1.0%1.8×
Q4 FY2324 May 2023+0.9%0.0%+10.0%1.6×
Q3 FY239 Feb 2023+3.6%-4.6%-5.2%5.5×
Q2 FY2312 Nov 2022-13.9%-22.0%-20.8%5.8×
Q1 FY2313 Aug 2022-6.2%-8.1%+5.2%4.4×
Q4 FY2230 May 2022-3.1%-1.0%-3.4%3.4×
Q3 FY229 Feb 2022-4.6%-10.9%-16.7%1.2×
Q2 FY2212 Nov 2021-1.9%-4.8%-9.1%2.2×
Q1 FY227 Aug 2021-3.3%-7.2%-14.1%1.1×
Q4 FY2130 May 2021+0.8%-3.8%+5.8%1.4×
Q3 FY2111 Feb 2021+3.5%+0.2%0.0%3.1×
Q2 FY214 Nov 2020-1.8%+2.4%+14.8%0.5×
Q1 FY2112 Aug 2020+2.6%-3.6%-12.6%0.7×
Q4 FY206 Jun 2020-1.4%+26.4%+44.4%3.3×
Q3 FY2013 Feb 2020-3.6%-5.3%-27.2%1.6×
Q2 FY2013 Nov 2019+3.2%+1.9%-0.1%2.3×
Q1 FY2013 Aug 2019-1.8%-5.9%+4.2%1.6×
Q4 FY1928 May 2019+3.4%-0.9%-9.4%6.3×
Q3 FY1928 Feb 2019+0.3%+3.0%-0.2%1.4×
Q2 FY1922 Nov 2018+0.4%+0.1%-4.0%0.5×
Q1 FY192 Aug 2018+2.0%-4.2%+11.7%1.7×
Q4 FY1821 Jun 2018-1.7%-1.4%-11.2%0.2×
Q3 FY1822 Feb 2018-0.6%-3.6%-17.6%0.6×
Q2 FY1818 Dec 2017+0.6%+3.2%+1.6%0.4×
Q1 FY1821 Sept 2017+0.4%-4.2%-7.2%10.0×
Q4 FY1710 Jun 2017+0.4%+1.7%+2.6%0.3×
Q3 FY1713 Feb 2017-1.4%-3.2%-6.2%0.5×
Q2 FY177 Nov 2016+2.4%-10.0%-6.5%0.6×
Q1 FY1713 Aug 2016-2.1%+3.7%+2.4%0.2×
Q4 FY1616 May 2016+0.9%-5.2%+1.9%0.8×
Q3 FY1612 Feb 2016+1.3%-4.4%+5.5%1.1×
Q2 FY169 Nov 2015-0.3%+3.0%+14.1%0.6×
Q1 FY1611 Aug 2015-6.3%-5.1%-19.1%1.2×
Q4 FY154 Jun 2015-0.6%-0.7%+6.3%0.6×
Q3 FY1510 Feb 2015+0.7%+2.1%+11.8%0.5×
Q2 FY1518 Nov 2014-0.6%-5.5%-9.4%0.7×
Q1 FY1514 Aug 2014+0.7%-1.2%+26.1%1.2×
Q4 FY147 Jun 2014+0.5%-3.1%+24.7%0.9×
Q3 FY1412 Feb 2014+4.6%+15.6%+16.8%0.4×
Q2 FY1422 Nov 2013-1.8%-4.8%+16.7%0.1×
Q1 FY1419 Aug 2013-3.3%-8.8%-3.6%0.0×
Q4 FY1320 Jun 2013-10.4%-10.8%-17.7%3.4×
Q3 FY1320 Feb 2013+0.7%+8.4%-3.1%2.6×
Q2 FY1316 Nov 2012+0.5%+1.6%-0.5%0.0×
Q1 FY1313 Aug 2012-0.3%+4.7%+4.4%0.2×
Q4 FY1211 May 2012-4.7%-6.3%-10.3%0.4×
Q3 FY1220 Feb 2012-0.6%+0.3%-9.1%2.0×
Q2 FY122 Nov 2011+0.3%+0.9%-8.5%1.5×
Q1 FY128 Aug 2011-7.1%-7.4%-13.2%0.6×
Q4 FY1112 May 2011-1.0%-1.0%+4.1%0.3×
Q3 FY1129 Jan 2011-0.8%-0.5%-3.7%0.4×
Q2 FY111 Nov 2010+0.5%+2.4%+3.4%0.9×
Q1 FY1123 Jul 2010-0.3%+3.6%+11.4%3.1×
Q4 FY1012 May 2010+0.6%-2.6%-2.9%0.2×
Q3 FY1030 Jan 2010+1.0%0.0%+5.9%0.4×
Q2 FY1028 Oct 2009-2.8%-3.5%-5.2%0.1×
Q1 FY1025 Jul 2009-3.5%+0.4%+8.8%0.5×
Q4 FY0930 Apr 20090.0%+0.5%+55.4%9.9×
Q3 FY0927 Jan 2009-2.0%+0.7%-2.0%0.3×
Q2 FY091 Nov 2008-3.3%-2.9%-25.4%1.5×
Q1 FY0930 Jul 2008-0.4%-1.8%-6.3%3.1×
Q4 FY0830 Apr 2008+3.1%+11.7%+36.1%1.5×
Q3 FY0831 Jan 2008-2.0%-3.6%-9.9%0.4×
Q2 FY0829 Oct 2007-1.4%-2.8%-2.0%1.5×
Q1 FY0830 Jul 2007-3.3%-8.7%-13.4%3.5×
Q4 FY0730 Apr 2007+1.9%+8.4%+5.6%0.9×
Average-1.0%-1.4%+1.4%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+30.4%
Profit YoY+57.4%
Interest cost YoY+9.1%
Revenue QoQ+52.7%
Profit QoQ+90.6%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+12.4%+17.4%+24.4%+8.1%+15.0%—
Profit+40.6%+55.7%+189.5%+5.3%+24.2%—

Key data

Open481.55
Day range472.00 – 484.20
52-week range270.10 – 535.00
From 52w high-11.5%
RSI (14)47.0
ATR (14)22.44
Volume1.94L
Avg volume (20D)7.00L
Rel volume0.28×
Volatility (1Y)49.5%
Turnover₹9.2Cr
Traded value (NSE)₹9.2Cr
VWAP475.78
SMA 50 / 200466.03 / 402.88
Price band20%

Delivery percentage

Latest · 20 Nov 202654.0%
20-day avg40.5%
1-year avg42.2%
Percentile (own history)36th
Range1.2–100.0%
Sessions3,527

Over the last 20 sessions SMSPHARMA settled 40.5% of its traded quantity, which is ordinary for an NSE equity. That is in line with its own one-year average of 42.2%. The latest session ranks higher than 36% of the 3,527 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.08%
Dividend, trailing 12M₹0.40
Paid every year for6 yr
Shareholders34.9K · +10.8% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy70 days ago

Performance returns

1D1W1M3M6M1Y
Price-1.68%-6.85%+10.40%+32.75%+11.13%+65.88%

Valuation

Market cap₹4,432 Cr
Market cap (NSE)₹4,432 Cr
Free-float cap₹1,415 Cr
P/E (TTM)37.8
P/E (NSE)38.5
EPS (TTM)12.52
P/B5.3
Net margin (TTM)12.1%
Other income / PBT6.8%
ROE14.9%
Debt / equity0.41
Shares outstanding9.37Cr
Listed28 Feb 2007

Ownership

Promoter68.07%
Promoter Δ QoQ0.00 pp
Public31.93%
FII1.18%
DII0.20%
Pledged17.99%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)210.4237.9207.0316.1
YoY chg+21.4%-4.1%+5.6%+30.4%
Net profit (₹ Cr)23.532.720.939.9
YoY chg+28.7%+61.0%+2.0%+57.4%
Net margin11.2%13.7%10.1%12.6%
EPS2.593.582.234.26

Shareholding over time

By quarter

30 Sept 2026 · promoter 68.07% · public 31.93%
30 Sept 2019: promoter 67.30%30 Jun 2021: promoter 67.29%30 Sept 2021: promoter 67.29%31 Dec 2021: promoter 67.29%31 Mar 2022: promoter 67.29%30 Jun 2022: promoter 64.17%30 Sept 2022: promoter 64.17%31 Dec 2022: promoter 64.17%31 Mar 2023: promoter 64.29%30 Jun 2023: promoter 64.32%30 Sept 2023: promoter 64.32%31 Dec 2023: promoter 64.32%31 Mar 2024: promoter 64.67%30 Jun 2024: promoter 64.67%30 Sept 2024: promoter 64.67%31 Dec 2024: promoter 64.67%27 Mar 2025: promoter 66.26%31 Mar 2025: promoter 66.26%30 Jun 2025: promoter 66.26%10 Sept 2025: promoter 68.07%30 Sept 2025: promoter 68.07%31 Dec 2025: promoter 68.07%31 Mar 2026: promoter 68.07%30 Jun 2026: promoter 68.07%30 Sept 2026: promoter 68.07%
2019-092026-09
  • Promoter
  • Public and others
Promoter
68.07%
Public
31.93%
Promoter change
0.00 pp
Filed
8 Oct 2026
FII
1.18%
DII
0.20%
Promoter pledged
17.99%

Who the public is

Mutual funds
0.00%

-2.81 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
1.18%

+0.53 pp QoQ

Retail ≤ ₹2L
18.35%

+0.89 pp QoQ

HNI > ₹2L
7.50%

+0.92 pp QoQ

NRI
2.16%

-0.15 pp QoQ

Bodies corporate
1.85%

+0.44 pp QoQ

Shareholders
34,904

+10.8% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
RAMESH BABU POTLURIPromoter · Individual19.38%
VAMSI KRISHNA POTLURIPromoter · Individual16.90%
HIMA BINDU POTLURIPromoter · Individual16.03%
POTLURI INFRA PROJECTS LLPPromoter · Corporate9.45%
TRILOK POTLURIPromoter · Individual5.01%
ANIRUDDH MUNDRAIndividual1.84%
Venkata Subbaraju Penmatsa HUFIndividual1.60%
ALPANA MUNDRAIndividual1.50%
VENKATA PRAVEEN TALLURIIndividual1.41%
SUDEEPTHI GOPINEEDIIndividual1.41%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 23 Sept 2013 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹0.40₹0.40
FY2025-261₹0.40₹0.40
FY2024-251₹0.40₹0.40
FY2023-241₹0.30₹0.30
FY2022-231₹0.30₹0.30
FY2021-221₹0.30₹0.30
FY2019-202₹0.50₹0.50
FY2018-191₹0.25₹0.25
FY2017-181₹0.20₹0.20
FY2016-171₹0.20₹0.20
FY2015-161₹2.00₹0.20
FY2014-151₹2.00₹0.20
FY2013-141₹2.00₹0.20
Ex-dateRecord dateDeclaredAdjusted
22 Sept 202622 Sept 2026₹0.40₹0.40
22 Sept 2025—₹0.40₹0.40
23 Sept 2024—₹0.40₹0.40
22 Sept 2023—₹0.30₹0.30
22 Sept 2022—₹0.30₹0.30
22 Sept 2021—₹0.30₹0.30
26 Mar 2020—₹0.25₹0.25
19 Sept 2019—₹0.25₹0.25
11 Sept 2018—₹0.25₹0.25
20 Sept 2017—₹0.20₹0.20
22 Sept 2016—₹0.20₹0.20
22 Sept 2015—₹2.00₹0.20
23 Sept 2014—₹2.00₹0.20
23 Sept 2013—₹2.00₹0.20

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
3.4 years ago
Disclosures on record
62
33 open-market of the newest 62
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
13 Nov 2026POTLURU JHANSILAXMIRelativeSell2.0K₹10.5L527.0020.9K → 18.9K0.02%-0.00 pp7(2)told 12 Nov 2026
21 Sept 2026NVV SatyanarayanaEmployeeSell2.0K₹9.6L466.0021.1K → 19.0K0.02%-0.00 pp7(2)told 17 Sept 2026
21 Sept 2026NVV SatyanarayanaEmployeeSell1.0K₹4.8L480.5019.0K → 18.0K0.01%-0.00 pp7(2)told 17 Sept 2026
24 Aug 2026N. Srilakshmi PadminiRelativeBuy3.0K₹10.7L356.0741.1K → 44.1K0.04%+0.00 pp7(2)told 21 Aug 2026
2 Jun 2026P. Deepthi SriRelativeSell5.0K₹15.8L316.008.9K → 3.9K0.00%0.00 pp7(2)told 2 Jun 2026
16 Mar 2026P. ManideepOtherSell2.5K₹10.1L404.4025.9K → 23.4K0.02%-0.00 pp7(2)told 12 Mar 2026
28 Feb 2026P. Srinivasa RaoEmployeeSell3.0K₹11.9L395.163.0K → 280.00%0.00 pp7(2)told 28 Feb 2026
28 Feb 2026P. Srinivasa RaoEmployeeSell2.0K₹7.8L389.895.0K → 3.0K0.00%0.00 pp7(2)told 28 Feb 2026
28 Feb 2026G. Suresh KumarDirectorSell5.0K₹19.8L395.6315.0K → 10.0K0.01%-0.00 pp7(2)told 28 Feb 2026
24 Feb 2026G. Suresh KumarDirectorSell1.0K₹3.7L372.9016.0K → 15.0K0.02%-0.00 pp7(2)told 23 Feb 2026
19 Feb 2026G. Suresh KumarDirectorSell1.1K₹4.1L369.8017.1K → 16.0K0.02%-0.00 pp7(2)told 19 Feb 2026
28 Nov 2025G. Suresh KumarDirectorSell3.0K₹9.0L298.5020.1K → 17.1K0.02%-0.00 pp7(2)told 28 Nov 2025
21 Jun 2023TVT INFRACON LLPPromoterBuy20.0K₹18.8L93.77— → 20.0K0.02%7(2)told 21 Jun 2023
21 Dec 2020Krishna Chaitanya PotluriOtherSell11.3K₹12.2L108.2411.3K → —0.00%7(2)told 19 Dec 2020
26 Nov 2020Sudeepthi GopineediPromoterSell4.05L₹3.4Cr83.9517.50L → 13.45L1.59%-0.48 pp7(2)told 25 Nov 2020
26 Nov 2020TVVSN Murthy - HUFPromoterSell33.95L₹28.1Cr82.6839.81L → 5.86L0.69%-4.00 pp7(2)told 25 Nov 2020
26 Nov 2020Potluri Laboratories Private LimitedPromoterBuy4.66L₹3.9Cr83.956.54L → 11.20L1.32%+0.55 pp7(2)told 25 Nov 2020
26 Nov 2020POTLURI INFRA PROJECTS LLPPromoterBuy1.34L₹1.1Cr84.0059.70L → 61.04L7.21%+0.16 pp7(2)told 25 Nov 2020
26 Nov 2020Vamsi Krishna PotluriPromoterBuy32.00L₹26.4Cr82.6048.11L → 80.11L9.46%+3.78 pp7(2)told 25 Nov 2020
19 Aug 2020Ramesh Babu PotluriKMPSell4.22L₹3.9Cr93.451.45Cr → 1.41Cr16.64%-0.50 pp7(2)told 18 Aug 2020
19 Aug 2020Potluri Laboratories Private LimitedPromoterBuy4.22L₹3.9Cr93.452.32L → 6.54L0.77%+0.50 pp7(2)told 18 Aug 2020
11 Mar 2020Hima Bindu PotluriPromoterBuy10.25L₹3.7Cr36.571.24Cr → 1.34Cr15.83%+1.21 pp7(2)told 7 Mar 2020
11 Mar 2020Vamsi Krishna PotluriRelativeBuy27.60L₹10.0Cr36.2520.51L → 48.11L5.68%+3.26 pp7(2)told 7 Mar 2020
11 Mar 2020TVVSN MurthyPromoterSell27.60L₹10.0Cr36.2582.27L → 54.67L6.46%-3.26 pp7(2)told 7 Mar 2020
11 Mar 2020T.AnnapurnaPromoterSell10.25L₹3.7Cr36.4743.90L → 33.65L3.98%-1.21 pp7(2)told 7 Mar 2020
20 Jun 2017Potluri laboratories Private LimitedPromoterBuy2.25L₹1.9Cr83.157.4K → 2.32L0.27%+0.26 pp7(2)told 20 Jun 2017
20 Jun 2017Potluri Infra Projects LLPPromoterBuy1.10L₹91.4L83.0558.60L → 59.70L7.05%+0.13 pp7(2)told 20 Jun 2017
1 Oct 2016RAMESH BABU POTLURIPromoterBuy31.50L₹29.8Cr94.601.14Cr → 1.45Cr17.14%+3.72 pp7(2)told 30 Sept 2016
27 May 2016N Durga PrasadEmployeeBuy14.9K₹14.0L94.092.35L → 2.50L0.30%+0.02 pp7(2)told 26 May 2016
16 May 2016N Durga PrasadEmployeeSell15.0K₹14.6L97.332.50L → 2.35L0.28%-0.02 pp7(2)told 13 May 2016
25 Feb 2016SEETA RAMA BRAHMAM POTLURUEmployeeBuy6.5K₹6.3L97.7990.7K → 97.1K0.12%+0.01 pp7(2)told 25 Feb 2016
9 Feb 2016SEETA RAMA BRAHMAM POTLURUEmployeeBuy25.1K₹25.2L100.3865.5K → 90.7K0.11%+0.03 pp7(2)told 8 Feb 2016
4 Dec 2015Potluri Laboratories Private LimitedPromoterSell93.0K₹8.5Cr916.1093.7K → 7420.01%-1.10 pp7(2)told 2 Dec 2015

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Filings

CSV
Loading…

Bulk & block deals · 11 Sept 2026

CSV
12 of 92 deals
By year
DateDealClientQuantityPriceValue
11 Sept 2026Sell · bulkMICROCURVES TRADING PRIVATE LIMITED5.47L454.45₹24.8Cr
11 Sept 2026Buy · bulkMICROCURVES TRADING PRIVATE LIMITED5.47L454.34₹24.8Cr
26 Nov 2025Sell · bulkMUSIGMA SECURITIES5.02L317.44₹15.9Cr
26 Nov 2025Buy · bulkMUSIGMA SECURITIES5.02L317.12₹15.9Cr
11 Sept 2025Sell · bulkMUSIGMA SECURITIES7.19L303.35₹21.8Cr
11 Sept 2025Buy · bulkMUSIGMA SECURITIES7.19L302.98₹21.8Cr
11 Sept 2025Sell · bulkGRAVITON RESEARCH CAPITAL LLP6.80L298.91₹20.3Cr
11 Sept 2025Buy · bulkGRAVITON RESEARCH CAPITAL LLP6.80L298.44₹20.3Cr
11 Sept 2025Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED6.57L302.79₹19.9Cr
11 Sept 2025Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED6.57L302.55₹19.9Cr
11 Sept 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP6.58L378.38₹24.9Cr
11 Sept 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP6.58L377.83₹24.9Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to SMSPHARMA.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations161.5245.8164.5196.7173.4248.2196.0242.4210.4237.9207.0316.1
Other income1.51.61.41.32.11.40.61.43.82.61.71.3
Total income163.0247.4165.8198.1175.5249.6196.6243.9214.2240.5208.7317.4
Total expenses146.4225.7144.0178.5153.0221.1172.3209.8183.0213.5181.5264.6
└ Finance costs6.05.64.74.64.25.15.85.76.25.35.55.7
└ Depreciation8.07.98.48.68.78.69.810.010.010.110.010.4
Profit before tax16.521.721.819.522.428.524.434.031.227.127.252.8
Tax expense4.25.75.55.75.48.45.78.98.06.17.013.2
Net profit11.517.316.514.118.220.320.525.323.532.720.939.9
EPS1.362.041.951.692.152.402.312.842.593.582.234.26
Net margin7.11%7.03%10.02%7.17%10.52%8.18%10.45%10.44%11.15%13.75%10.10%12.61%
PBT margin10.23%8.84%13.27%9.93%12.94%11.49%12.43%14.04%14.81%11.38%13.14%16.71%
Tax rate25.63%26.15%24.99%29.07%23.89%29.60%23.20%26.18%25.58%22.55%25.75%25.08%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 4 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets879.6977.11,034.11,134.71,152.71,276.51,362.41,460.6
Current assets410.6500.3533.9581.9554.5661.1638.0685.7
└ Cash & equivalents7.432.836.08.941.499.545.936.1
└ Other bank balances0.10.10.20.20.20.20.20.2
└ Current investments0.00.00.00.00.00.00.00.0
└ Trade receivables148.3154.4236.2213.4203.2221.4215.9243.3
└ Inventories223.5277.4233.7315.3284.7317.5351.2377.7
Total equity460.5479.0536.3563.5639.6729.3785.8842.7
└ Attributable to owners460.5479.0536.3563.5639.6729.3785.8842.7
└ Non-controlling interest0.00.0——0.00.00.00.0
└ Share capital8.58.58.58.58.99.49.49.4
Borrowings252.5275.6280.2285.2310.8324.3365.0349.5
└ Current131.4161.9158.1134.6171.4203.0193.4196.3
└ Non-current121.1113.7122.1150.6139.4121.3171.6153.1
Trade payables113.1159.2151.3215.1113.9139.7120.4170.5
Current liabilities254.9341.4331.7375.4324.4375.2353.0411.2
Total liabilities419.1498.1497.8571.2513.0547.1576.6618.0
Net debt245.0242.7244.0276.1269.2224.6319.0313.2
Debt / equity0.550.580.520.510.490.440.460.41
Current ratio1.611.471.611.551.711.761.811.67

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow22.533.550.148.781.742.359.2105.8
└ Capex(29.9)(19.9)(52.2)(71.2)(123.4)(29.7)(130.6)(85.9)
Free cash flow(7.5)13.6(2.0)(22.5)(41.7)12.7(71.3)19.9
Investing cash flow(29.7)(19.8)(52.1)(71.4)(123.4)(30.5)(130.8)(85.4)
Financing cash flow(32.0)11.830.7(4.4)47.146.376.0(30.1)
└ Dividends paid(2.5)0.0(2.5)0.0(3.4)(3.5)(3.5)(3.7)
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(39.2)25.528.7(27.1)5.458.14.5(9.8)

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

SMSPHARMA at a glance

  • SMSPHARMA closed at ₹473.25 on 20 Nov 2026, -1.68% on the day, +65.9% over one year, 11.5% below its 52-week high of ₹535.
  • Delivery was 54.0% of traded quantity on 20 Nov 2026, the 36th percentile of its own 3,527 sessions with a reading (20-session average 40.5%, 1-year average 42.2%).
  • Market capitalisation is ₹4,432 crore at a trailing P/E of 37.8 (trailing EPS ₹12.52).
  • Q2 FY27 results (consolidated, filed 4 Nov 2026): revenue ₹316 crore (+30.4% year on year), net profit ₹40 crore (+57.4%); the price moved -1.7% on the first session after.
  • Promoters held 68.07% at 30 Sept 2026, unchanged on the previous filing, with 17.99% of promoter shares pledged.
  • Q3 FY27 results are expected between 7 Feb 2027 and 12 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE812G01025
SeriesEQ
Listed28 Feb 2007
NSE market cap · 17 Nov 2026₹4,563 Cr
Free-float market cap (NSE)₹1,426 Cr
Shares outstanding (NSE)9.37Cr
History from28 Feb 2007
Sessions4,857
Turnover rank#532

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.